(BE) Bloom Energy - Overview
Stock: Fuel Cell, Electrolyzer, Energy Server, Power Generation
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 100% |
| Relative Tail Risk | -5.72% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.27 |
| Alpha | 463.79 |
| Character TTM | |
|---|---|
| Beta | 1.879 |
| Beta Downside | 2.401 |
| Drawdowns 3y | |
|---|---|
| Max DD | 64.85% |
| CAGR/Max DD | 1.27 |
Description: BE Bloom Energy December 19, 2025
Bloom Energy Corp (NYSE:BE) designs, manufactures, and installs solid-oxide fuel cell systems that generate on-site electricity from natural gas, biogas, hydrogen, or blended fuels via an electro-chemical process that eliminates combustion.
The firm’s flagship product, the Bloom Energy Server, is marketed to a diversified customer base-including utilities, data centers, hospitals, universities, biotech firms, and manufacturers-through both direct sales teams and indirect channel partners.
Bloom also offers the Bloom Electrolyzer, a complementary hydrogen-production unit that enables customers to produce green hydrogen on-site, positioning the company within the emerging hydrogen economy.
Key recent metrics (FY 2023): revenue of approximately $1.2 billion, a backlog of roughly $2.5 billion, and cumulative installed capacity of about 2.5 GW of fuel-cell power, reflecting a ~15 % YoY increase in capacity deployments driven largely by data-center and industrial customers.
Sector drivers that could materially affect Bloom’s growth include accelerating corporate decarbonization targets, expanding U.S. and EU clean-energy incentives for on-site generation, and the rising cost-competitiveness of hydrogen as a dispatchable renewable fuel.
For a deeper, data-driven look at Bloom Energy’s valuation and risk profile, consider reviewing the analyst notes available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 15.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 15.91 > 1.0 |
| NWC/Revenue: 170.8% < 20% (prev 106.2%; Δ 64.66% < -1%) |
| CFO/TA 0.04 > 3% & CFO 180.1m > Net Income 15.3m |
| Net Debt (292.7m) to EBITDA (129.2m): 2.27 < 3 |
| Current Ratio: 5.98 > 1.5 & < 3 |
| Outstanding Shares: last quarter (234.9m) vs 12m ago 3.06% < -2% |
| Gross Margin: 33.24% > 18% (prev 0.25%; Δ 3299 % > 0.5%) |
| Asset Turnover: 51.95% > 50% (prev 48.32%; Δ 3.64% > 0%) |
| Interest Coverage Ratio: 1.32 > 6 (EBITDA TTM 129.2m / Interest Expense TTM 59.2m) |
Altman Z'' 0.67
| A: 0.71 (Total Current Assets 3.73b - Total Current Liabilities 623.8m) / Total Assets 4.40b |
| B: -0.91 (Retained Earnings -3.99b / Total Assets 4.40b) |
| C: 0.02 (EBIT TTM 77.9m / Avg Total Assets 3.50b) |
| D: -1.11 (Book Value of Equity -3.99b / Total Liabilities 3.60b) |
| Altman-Z'' Score: 0.67 = B |
Beneish M -3.36
| DSRI: 0.42 (Receivables 434.1m/711.9m, Revenue 1.82b/1.26b) |
| GMI: 0.76 (GM 33.24% / 25.41%) |
| AQI: 1.12 (AQ_t 0.04 / AQ_t-1 0.03) |
| SGI: 1.45 (Revenue 1.82b / 1.26b) |
| TATA: -0.04 (NI 15.3m - CFO 180.1m) / TA 4.40b) |
| Beneish M-Score: -3.36 (Cap -4..+1) = AA |
What is the price of BE shares?
Over the past week, the price has changed by -8.39%, over one month by +17.39%, over three months by +2.73% and over the past year by +463.33%.
Is BE a buy, sell or hold?
- StrongBuy: 8
- Buy: 3
- Hold: 10
- Sell: 2
- StrongSell: 1
What are the forecasts/targets for the BE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 134.8 | -5.7% |
| Analysts Target Price | 134.8 | -5.7% |
| ValueRay Target Price | 155.8 | 8.9% |
BE Fundamental Data Overview February 08, 2026
P/S = 22.0239
P/B = 52.1113
P/EG = 6.6218
Revenue TTM = 1.82b USD
EBIT TTM = 77.9m USD
EBITDA TTM = 129.2m USD
Long Term Debt = 1.13b USD (from longTermDebt, last quarter)
Short Term Debt = 26.2m USD (from shortTermDebt, last quarter)
Debt = 2.75b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 292.7m USD (from netDebt column, last quarter)
Enterprise Value = 42.21b USD (40.05b + Debt 2.75b - CCE 595.1m)
Interest Coverage Ratio = 1.32 (Ebit TTM 77.9m / Interest Expense TTM 59.2m)
EV/FCF = 312.2x (Enterprise Value 42.21b / FCF TTM 135.2m)
FCF Yield = 0.32% (FCF TTM 135.2m / Enterprise Value 42.21b)
FCF Margin = 7.43% (FCF TTM 135.2m / Revenue TTM 1.82b)
Net Margin = 0.84% (Net Income TTM 15.3m / Revenue TTM 1.82b)
Gross Margin = 33.24% ((Revenue TTM 1.82b - Cost of Revenue TTM 1.21b) / Revenue TTM)
Gross Margin QoQ = 29.22% (prev 36.09%)
Tobins Q-Ratio = 9.60 (Enterprise Value 42.21b / Total Assets 4.40b)
Interest Expense / Debt = 0.52% (Interest Expense 14.4m / Debt 2.75b)
Taxrate = 21.0% (US default 21%)
NOPAT = 61.6m (EBIT 77.9m * (1 - 21.00%))
Current Ratio = 5.98 (Total Current Assets 3.73b / Total Current Liabilities 623.8m)
Debt / Equity = 3.57 (Debt 2.75b / totalStockholderEquity, last quarter 768.6m)
Debt / EBITDA = 2.27 (Net Debt 292.7m / EBITDA 129.2m)
Debt / FCF = 2.17 (Net Debt 292.7m / FCF TTM 135.2m)
Total Stockholder Equity = 626.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.44% (Net Income 15.3m / Total Assets 4.40b)
RoE = 2.44% (Net Income TTM 15.3m / Total Stockholder Equity 626.0m)
RoCE = 4.44% (EBIT 77.9m / Capital Employed (Equity 626.0m + L.T.Debt 1.13b))
RoIC = 3.56% (NOPAT 61.6m / Invested Capital 1.73b)
WACC = 12.04% (E(40.05b)/V(42.80b) * Re(12.84%) + D(2.75b)/V(42.80b) * Rd(0.52%) * (1-Tc(0.21)))
Discount Rate = 12.84% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 10.47%
[DCF Debug] Terminal Value 55.34% ; FCFF base≈135.2m ; Y1≈91.6m ; Y5≈44.5m
Fair Price DCF = 0.78 (EV 512.4m - Net Debt 292.7m = Equity 219.7m / Shares 280.0m; r=12.04% [WACC]; 5y FCF grow -37.70% → 2.90% )
EPS Correlation: 65.55 | EPS CAGR: 178.1% | SUE: 1.92 | # QB: 1
Revenue Correlation: 55.02 | Revenue CAGR: 11.73% | SUE: 1.59 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.10 | Chg30d=+0.049 | Revisions Net=+1 | Analysts=10
EPS current Year (2026-12-31): EPS=1.30 | Chg30d=+0.224 | Revisions Net=+5 | Growth EPS=+71.3% | Growth Revenue=+57.8%
EPS next Year (2027-12-31): EPS=3.00 | Chg30d=+0.342 | Revisions Net=+0 | Growth EPS=+130.3% | Growth Revenue=+52.3%